Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 53 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
521 17.4 months HER2-negative advanced breast cancer 5 Chemotherapy
Northwestern University Feinberg School of Medicine United States 1/2013
Treatment Details: Patients: This phase 2 study involved female HER2-negative advanced breast cancer patients who were divided into two separate treatment groups. Group A had 119 patients with an average age
 
522 17.3 months Hepatocellular carcinoma 5 Biologic therapy
UCL Medical School United Kingdom 2/2013
Treatment Details: Patients: This phase 2 study involved untreated hepatocellular carcinoma patients who were divided into two separate treatment groups. Group A consisted of 42 patients with a median age of
 
523 17.3 months Recurrent epithelial ovarian cancer 5 Chemotherapy
St Joseph's Hospital United States 6/2014
Treatment Details: Patients: This phase 3 study involved recurrent epithelial ovarian cancer patients who were divided into two treatment groups. Group A had 458 patients with a median age of 59 years, while
 
524 17.3 months Advanced Melanoma 2 Immunotherapy
University of Medical Sciences Poland 5/2015
Treatment Details: Patients: This phase 2 study involved 77 advanced melanoma patients with an average age of 51.7 years; 48% were male. Treatment: Patients received immunotherapy with a melanoma vaccine
 
525 17.3 months Metastatic rcc 4 Biologic therapy
Immunotherapy
The Norwegian Radium Hospital Norway 6/2005
Treatment Details: Patients: This Phase II/III trial involved a total of 320 patients with progressive metastatic renal cell carcinoma. There were 222 men and 98 women. The ages ranged from 25 to 75. The me
 
526 17.3 months Metastatic NSCLC 3 Immunotherapy
Mary Crowley Cancer Research Centers United States 9/2008
Treatment Details: Patients: This phase 2 study involved 63 patients with metastatic non-small cell lung cancer. The average age was 64, ranging from 26 to 87 years of age. About half (56%) of the patients w
 
527 17.3 months Advanced breast cancer 5 Biologic therapy
Chemotherapy
Edinburgh Cancer Research Center United Kingdom 8/2010
Treatment Details: Patients This phase 3 study involved women with advanced breast cancer. Patients were separated into two treatment groups. Group A consisted of 207 women with a median age of 54 years and
 
528 17.3 months Newly diagnosed GBM 4 Biologic therapy
Chemotherapy
Radiation
Bellaria and Maggiore Hospitals Italy 1/2010
Treatment Details: Patients: This phase I/II study involved 20 patients with newly diagnosed glioblastoma. Their median age was 53.5, ranging from 33 to 67 years. There were twelve men and eight women in th
 
529 17.2 months Castration-resistant prostate cancer 5 Chemotherapy
Roswell Park Cancer Institute United States 5/2010
Treatment Details: Patients: This study involved patients with castration-refractory prostate cancer. Patients were divided into 2 separate treatment groups. Group A included 33 men with a median age of 68
 
530 17.2 months Advanced or metastatic colorectal cancer 4 Chemotherapy
Hospital Universitario Reina Sofia Spain 4/2004
Treatment Details: Patients: This Phase II trial involved 36 patients with advanced or metastatic colorectal cancer Treatment: The treatment consisted of two chemotherapy drugs irinotecan and 5-FU (5-fluo
 
Page 53 of 187  | Previous Page  | Next Page